Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

OBJECTIVES: Hydroxychloroquine is an antimalarial agent that has been used in systemic lupus erythematosus and rheumatoid arthritis treatment for many years. Recently, novel mechanisms of action have been proposed, thereby broadening the therapeutic perspective of this medication. The purpose of thi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: da Silva, Juliana Cruz, Mariz, Henrique Ataide, da Rocha Júnior, Laurindo Ferreira, Santana de Oliveira, Priscilla Stela, Dantas, Andrea Tavares, Duarte, Angela Luzia Branco Pinto, da Rocha Pitta, Ivan, Galdino, Suely Lins, da Rocha Pitta, Maira Galdino
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Aiheet:
Clinical Science
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674253/
https://ncbi.nlm.nih.gov/pubmed/23778483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2013(06)07
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia